Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04769492 · ClinicalTrials.gov registry record · NA

#ChopViolence/#ChopHIV

A NA study of HIV and Violence, sponsored by Hektoen Institute for Medical Research.

Recruiting
Registry status
NA
Development phase
525
Enrollment target
1
Study location

NCT04769492 is a NA study of HIV and Violence that is actively recruiting participants, run by Hektoen Institute for Medical Research. The registered enrollment target is 525 participants, above the 438-participant average among 303 other HIV trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04769492, a NA study of HIV and Violence, is actively recruiting participants, sponsored by Hektoen Institute for Medical Research.

RECRUITING
Registry status
NA
Development phase
525 participants
Enrollment target
1
Study location

Study Summary

Black young gay, bisexual and other men who have sex with men (B-YGBMSM) and transgender women (B-YTW) are disproportionately affected by HIV/AIDS in the U.S. Youth in the House Ball Community (HBC), a subculture of the Black gay community that offers a social network to freely express diverse sexual and gender identities, are among the most at-risk for HIV infection and loss to care, but barriers exist to the provision of HIV services within this community. One barrier is the increasing rates of violence. Interventions are needed that will interrupt the cycle of violence within the HBC to allow for adequate provision of HIV services and increased access to HIV care. The investigators propose to tailor the Cure Violence model for violence prevention for developmental-appropriateness, cultural-specificity and HIV relevance, then pilot test the new intervention (#ChopViolence/#ChopHIV) with B-YGBMSM and B-TW in the Chicago HBC. The proposed research activities will take place in six steps. In Step 1, the investigators will hold Youth Advisory Board meetings, finalize our assessment battery and conduct multiple baseline assessments (months 3, 9 \& 15; n=75 per assessment point) at HBC venues to track trends in violence (i.e., intimate partner, HBC and neighborhood violence), HIV stigma, substance use, mental health, sexual risk and HIV care engagement. In Step 2, the investigators will employ ADAPT-ITT strategies for adapting evidence-based interventions including conducting a series of focus groups (n=32) with youth and leaders from the HBC in order to identify persuasive messaging around decreasing violence and improving HIV outcomes. Based on the focus group data as well as consultation with community experts, the investigators will then tailor the intervention to be relevant for the Chicago HBC and develop training materials along with standard operating procedures. In Step 3, the investigators will identify, recruit and train trusted members of the HBC to work as

Conditions Studied

Interventions

  • OTHER #ChopViolence/#ChopHIV

Study Locations (1)

Illinois

  • Cook County Health - Chicago

Trial Details

FieldValue
Enrollment Target 525 participants
Start Date 2020-07-30
Est. Completion 2024-08-30
Phase NA

What the Registry Record Tells You About NCT04769492

The ClinicalTrials.gov registry entry for NCT04769492 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 525 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 438-participant average among 303 other HIV trials with a reported enrollment target (20% higher). The listed sponsor is Hektoen Institute for Medical Research, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which #ChopViolence/#ChopHIV is the first listed.

NCT04769492 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04769492 about?

NCT04769492 is a clinical study titled "#ChopViolence/#ChopHIV". Black young gay, bisexual and other men who have sex with men (B-YGBMSM) and transgender women (B-YTW) are disproportionately affected by HIV/AIDS in the U.S. Youth in the House Ball Community (HBC), a subculture of the Black gay community that offers a social network to freely express diverse sexua...

What is the current status of trial NCT04769492?

This trial is currently recruiting. It is a NA study. The enrollment target is 525 participants. The study started on 2020-07-30. Estimated completion is 2024-08-30.

What conditions does trial NCT04769492 study?

This clinical trial studies the following conditions: HIV, Violence.

What interventions are being tested in trial NCT04769492?

The interventions under investigation include: #ChopViolence/#ChopHIV (OTHER).

Who is sponsoring clinical trial NCT04769492?

This trial is sponsored by Hektoen Institute for Medical Research, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04769492 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.